Advanced search

Filter By:

Journal Check one or more journals to show results from those journals only.
Article type Check one or more article types to show results from those article types only.
Subject Check one or more subjects to show results from those subjects only.
Date Choose a date option to show results from those dates only.

Custom date range

Clear all filters
Sort by:
Showing 1–7 of 7 results
Advanced filters: Author: Martina Turroja Clear advanced filters

  • In a cohort of 87 individuals with COVID-19, the memory B cell response at 6.2 months after the onset of disease evolves in a manner that is consistent with the persistence of SARS-CoV-2 antigen.

    • Christian Gaebler
    • Zijun Wang
    • Michel C. Nussenzweig
    Research
    Nature
    Volume: 591, P: 639-644

  • The Moderna (mRNA-1273) and Pfizer–BioNTech (BNT162b2) vaccines elicit anti-RBD antibodies similar to those elicited through natural infection with SARS-CoV-2, but their potent neutralizing activity was reduced or abolished by new viral variants of concern.

    • Zijun Wang
    • Fabian Schmidt
    • Michel C. Nussenzweig
    Research
    Nature
    Volume: 592, P: 616-622

  • Individual memory antibodies selected over time by natural infection with SARS-CoV-2 have greater potency and breadth than antibodies elicited by vaccination, whereas the overall neutralizing potency of plasma is greater following vaccination.

    • Alice Cho
    • Frauke Muecksch
    • Michel C. Nussenzweig
    ResearchOpen Access
    Nature
    Volume: 600, P: 517-522

  • Pre-existing high-affinity antibodies alter germinal centre and memory B cell selection by lowering the activation threshold for B cells and through direct masking of their cognate epitopes, thereby permitting a diverse set of abundant lower-affinity clones targeting alternate epitopes to participate in the immune response.

    • Dennis Schaefer-Babajew
    • Zijun Wang
    • Michel C. Nussenzweig
    ResearchOpen Access
    Nature
    Volume: 613, P: 735-742

  • A clinical study shows that immunotherapy with anti-HIV-1 antibodies maintains prolonged viral suppression after anti-retroviral treatment is discontinued and affects the size and composition of the intact but not the defective proviral reservoir.

    • Christian Gaebler
    • Lilian Nogueira
    • Michel C. Nussenzweig
    ResearchOpen Access
    Nature
    Volume: 606, P: 368-374